why choose us

Course: Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong

CME Credits: 1.00

Released: 2022-02-25

Cases of myocarditis following the second dose of messenger RNA (mRNA) vaccine are accruing worldwide, especially in younger male adults and adolescents.- In weighing the risk of myocarditis against the benefit of preventing severe COVID-19, Norway, the UK, and Taiwan have suspended the second dose of mRNA vaccine for adolescents. Similarly, adolescents (aged 12-17 years) in Hong Kong have been recommended to receive 1 dose of BNT162b2 instead of 2 doses 21 days apart since September 15, 2021 ().


Educational Objective
To identify the key insights or developments described in this article


View Full Course